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Objective: We sought to determine whether pretreatment with a sodium/hydrogen-
exchange inhibitor (EMD 96 785) improves myocardial performance and reduces
myocardial edema after cardioplegic arrest and cardiopulmonary bypass.
Methods: Anesthetized dogs (n  13) were instrumented with vascular catheters,
myocardial ultrasonic crystals, and left ventricular micromanometers to measure
preload recruitable stroke work, maximum rate of pressure rise (positive and
negative), and left ventricular end-diastolic volume and pressure. Cardiac output
was measured by means of thermodilution. Myocardial tissue water content was
determined from sequential biopsy. After baseline measurements, hypothermic
(28°C) cardiopulmonary bypass was initiated. Cardioplegic arrest (4°C Bretschnei-
der crystalloid cardioplegic solution) was maintained for 2 hours, followed by
reperfusion-rewarming and separation from cardiopulmonary bypass. Preload re-
cruitable stroke work and myocardial tissue water content were measured at 30, 60,
and 120 minutes after bypass. EMD 96 785 (3 mg/kg) was given 15 minutes before
bypass, and 2 mol was given in the cardioplegic solution. Control animals received
the same volume of saline vehicle. Arterial–coronary sinus lactate difference was
similar in both animals receiving EMD 96 785 and control animals, suggesting
equivalent myocardial ischemia in each group.
Results: Myocardial tissue water content increased from baseline in both animals
receiving EMD 96 785 and control animals with cardiopulmonary bypass and
cardioplegic arrest but was statistically lower in animals receiving EMD 96 785
compared with control animals (range, 1.0%-1.5% lower in animals receiving EMD
96 785). Preload recruitable stroke work decreased from baseline (97  2 mm Hg)
at 30 (59  6 mm Hg) and 60 (72  9 mm Hg) minutes after cardiopulmonary
bypass and cardioplegic arrest in control animals; preload recruitable stroke work
did not decrease from baseline (98  2 mm Hg) in animals receiving EMD 96 785
and was statistically greater at 30 (88 5 mm Hg) and 60 (99 4 mm Hg) minutes
after bypass and arrest compared with control animals.
Conclusions: Sodium/hydrogen-exchanger inhibition decreases myocardial edema
immediately after cardiopulmonary bypass and cardioplegic arrest and improves
preload recruitable stroke work. Sodium/hydrogen-exchange inhibition during car-
diac procedures with cardiopulmonary bypass and cardioplegic arrest may be a
useful adjunct to improve myocardial performance in the immediate postbypass or
arrest period.
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The introduction of cardioplegia has dramat-ically improved myocardial protection dur-ing cardiac surgery.1 However, cardiopul-monary bypass (CPB) and cardioplegicarrest (CPA) have been shown to be a formof global myocardial ischemia-reperfusion
(I-R) that can induce post-CPB myocardial dysfunction.
Although most patients undergoing CPB and CPA do well,
some patients with limited myocardial reserve may be dif-
ficult to separate from CPB. Although post-CPB myocardial
contractile dysfunction is multifactorial, we have focused
on the relationship between myocardial edema and post-
CPB myocardial dysfunction.2-6 Because post-CPB/CPA
myocardial dysfunction is a potentially devastating compli-
cation, we have investigated cardioprotective strategies to
reduce post-CPB/CPA myocardial edema, thus improving
myocardial function.
Recent studies have shown that myocardial sodium/hy-
drogen (Na/H)-exchanger inhibition preserves myocar-
dial performance after global I-R.7-10 Myocardial ischemia
results in intracellular lactate accumulation and a concom-
itant decrease in intracellular pH. Na/H-exchange activ-
ity serves to normalize intracellular pH by exchanging in-
tracellular H for Na during intracellular lactate
accumulation.11,12 However, intracellular Na accumula-
tion may lead to a concomitant increase in intracellular
water. EMD 96 785 is a Na/H-exchanger inhibitor that is
selective for the myocardial isoform NHE-1. We hypothe-
sized that Na/H-exchanger inhibition during I-R associ-
ated with CPB/CPA would decrease myocardial edema and
improve post-CPB/CPA myocardial performance.13 In for-
mulating our hypothesis, we noted ex vivo studies of hyp-
oxia-reoxygenation and simulated normothermic CPA by
using Na/H-exchanger inhibition that reduced total myo-
cardial water content (MWC) and improved myocardial
performance.14,15 To test this hypothesis, we studied the
effects of Na/H-exchanger inhibition using EMD 96 785
before myocardial I-R on myocardial function and myocar-
dial fluid balance after CPB/CPA.
Na/H-exchanger inhibition has also been shown to
attenuate neutrophil activation and subsequent neutrophil-
mediated myocardial reperfusion injury.16 A secondary hy-
pothesis was that Na/H-exchanger inhibition decreased
myocardial leukosequestration. We measured myocardial
myeloperoxidase (MPO) after CPB/CPA to determine
whether Na/H-exchanger inhibition decreased myocar-
dial leukosequestration and whether this was associated
with improved post-CPB/CPA myocardial function.
Methods
Animal Preparation
All procedures were approved by the University of Texas Animal
Welfare Committee and were consistent with the “Guide for the
Care and Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources, National Research Council, and
published by the National Academy Press, revised 1996. Condi-
tioned dogs of either sex were anesthetized by means of intrave-
nous administration of 25 mg/kg thiopental sodium (Pentothal,
Abbott Laboratories, North Chicago, Ill) and underwent tracheal
intubation and mechanical ventilation with 100% oxygen by using
a volume-cycled respirator (Siemens-Elema AB, Solna, Sweden).
Anesthesia was maintained with intravenous infusion of 1% thio-
pental sodium in Ringer solution.
Fluid-filled catheters were placed into the left femoral artery
and vein and connected to pressure transducers for arterial pressure
monitoring, arterial blood sampling, and fluid administration, re-
spectively. A 7F Swan-Ganz thermodilution catheter (Baxter
Healthcare Corp, Edwards Divison, Santa Ana, Calif) was inserted
into the pulmonary artery through the right jugular vein for pres-
sure and cardiac output measurements. We then exposed the right
femoral artery for subsequent CPB cannulation. After a median
sternotomy and pericardiotomy, a 5F catheter was advanced into
the coronary sinus through a snare-secured purse-string stitch for
coronary sinus blood sampling. An umbilical tape was placed
around the inferior vena cava for cardiac preload manipulation. A
micromanometer-tipped pressure transducer (Millar Instruments,
Inc, Houston, Tex) was introduced into the left ventricular cavity
through the apex. Sonomicrometry crystals (10 MHz; Sonometrics
Corporation, London, Ontario, Canada) were placed in the left
ventricular subendocardium across the septum/free-wall axis of the
left ventricle. The crystals were then connected to a sonomicrome-
ter (Triton Technology Inc, Watsonville, Calif) for processing of
signals.
Hemodynamics and Preload Recruitable Stroke Work
Hemodynamic data were simultaneously logged into a Macintosh
Quadra 700 computer through an analog-to-digital data-acquisition
device (MacLab, World Precision Instruments, Inc, Sarasota, Fla).
Cardiac output was determined in duplicate by injecting 10 mL of
ice-cold Ringer solution. Left ventricular pressure was measured
with a micromanometer, and the left ventricular septum/free-wall
diameter was obtained with a sonomicrometer. Preload recruitable
stroke work (PRSW) was calculated as the slope of the relation
between left ventricular end-diastolic volume and left ventricular
stroke work, as previously described.2-5
MWC Determination
MWC for edema quantification was measured by using a micro-
gravimetric technique, as previously described.2,3 With a biopsy
needle (Tru-Cut; Baxter Healthcare Corp), transmyocardial biopsy
specimens were taken from the left ventricular anterior or antero-
lateral wall. Measurements were performed in triplicate.
Microscopic Analysis
From each dog, myocardial biopsy specimens were collected for
both light and electron microscopy. Samples were placed in 3%
buffered glutaraldehyde fixative (4°C) for later processing. In
brief, after fixation in 2% osmium tetroxide, dehydration in an
ethanol series, and substitution with propylene oxide, specimens
were embedded in epoxy resin and polymerized at 60°C overnight.
Semithin (0.5-1 m) sections were prepared and stained with
toluidine blue for light optic selection of areas of interest. Samples
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were reviewed by a blinded investigator. A modification of a
point-counting technique was used to obtain morphometric quan-
tification during light microscopic observation of the toluidine
blue–stained sections. Percentage volumes were calculated from
(1) interstitial space, which is reflective of interstitial fluid content;
(2) cytologically normal cardiomyocytes; and (3) cardiomyocytes
with significant injury with cytoplasmic clearing (edema) and
contraction band formation.17
Determination of Myocardial MPO
MPO tissue levels were analyzed as an index of neutrophil infil-
tration in the tissue. The presence of MPO, an enzyme specific for
neutrophils, was determined in myocardial tissue by using the
method described by Bradley and colleagues18 and modified by
Mullane and colleagues.19
Na/H-Exchanger Inhibition
EMD 96 785 is a specific Na/H-exchanger inhibitor. In vitro
assays studying the inhibitory effects at 10 mol/L showed only a
13% reduction in Na/Ca2-exchanger activity (84% reduction in
Na/H-exchanger activity at the same dose). This level of Na/
Ca2-exchanger inhibition is considered insignificant. Plasma con-
centrations of EMD 96 785 were measured in some dogs and
ranged from 1900 ng/mL after bolus injection to 500 ng/mL at the
end of the experiment.
CPB Techniques
After instrumentation, heparin (250 IU/kg) was given intrave-
nously for systemic anticoagulation, followed by additional doses
of 100 IU/kg given every 60 minutes throughout the experiment.
Extracorporeal circulation was performed by using a 14F arterial
perfusion cannula placed into the right femoral artery and a 2-stage
venous cannula (36F and 46F) in the right atrium–inferior vena
cava. The left ventricle was vented with a 12F catheter inserted
through the left atrium. The extracorporeal circuit (model 7000;
Sarns, Inc, Ann Arbor, Mich) and the membrane oxygenator
(HVRF 3700, COBE Cardiovascular, Inc, Arvada, Colo) were
primed with 800 mL of Ringer solution and 1000 IU of heparin.
Approximately 5 minutes after initiating CPB, CPA was initiated
with 500 mL of 4°C crystalloid cardioplegic solution (Bretschnei-
der) and lasted for 2 hours.20 We gave an additional dose of 100
mL of cardioplegic solution after 60 minutes of cardiac arrest.
External myocardial cooling was accomplished by means of inter-
mittent instillation of iced (4°C) saline solution into the pericar-
dium. Hearts were then reperfused on normothermic CPB for 40
minutes. Thereafter, we weaned the dogs from CPB and removed
all cannulas. During ischemia, animals were systemically cooled to
28°C with a heat exchanger. We kept CPB flow between 40 and 60
mL  kg1  min1 at 28°C to maintain a mean systemic perfusion
pressure of 40 to 70 mm Hg.
Experimental Design
Systemic pretreatment was used to ensure drug availability during
the ischemic period before CPA. Direct infusion by means of
cardioplegia ensures drug delivery at the time of ischemia (CPA),
and it decreases the variability of drug delivery that may occur
during the hemodilution that occurs with initiation of CPB. EMD
96 785 (3 mg/kg) was given intravenously 15 minutes before CPB
and was present at a final concentration of 2 mol in the cardiople-
gic solution. Treated dogs (n  6) were compared with control
animals (n  7) that were subjected to the same protocol, except
that an equal volume of saline vehicle was used instead of EMD 96
785. These doses were chosen after in vitro and in vivo experi-
ments evaluating binding specificity and efficacy, as well as ex-
periments with CPB circuits, to ensure that no significant binding
occurred to the oxygenator.
Experimental Protocol
After at least 30 minutes for stabilization after the completion of
instrumentation, preischemic hemodynamic values were recorded.
Myocardial samples for MWC determination were collected, as
described above. Arterial and coronary sinus blood samples were
frozen at 20°C for later determination of arterio–coronary sinus
lactate difference and creatine kinase, lactate dehydrogenase, and
troponin I levels (Sigma Diagnostics, Poole, Dorset, United King-
dom).
Coronary sinus and arterial blood samples were collected si-
multaneously at 1 and 15 minutes during reperfusion. Addition-
ally, MWC was determined at 15 minutes of reperfusion. Post-
ischemic hemodynamic recovery data were recorded at 30, 60, and
120 minutes after separation from CPB.
Statistical Analysis
All data presented are means  SEM. Data analysis was carried
out with Statistica software (StatSoft Inc, Tulsa, Okla). Time
courses of each measured parameter were examined within groups
by using analysis of variance for repeated measures and the Tukey
HSD (honestly significant difference) test. Time-point compari-
sons between groups were made with the Student t test.
Results
Figure 1 demonstrates an increase in MWC with CPB/
CPA in both groups. MWC in animals receiving EMD 96
785 was statistically lower compared with that in control
animals at each time point. These control data are similar to
those previously reported from our laboratory.2,3 Figure 2
demonstrates a statistically significant decrease of PRSW in
control animals at 30 minutes after CPB and 60 minutes
after CPB compared with baseline values and values in
EMD 96 785–treated animals. Table 1 demonstrates the
hemodynamic data. At the same left ventricular end-dia-
stolic volume and left ventricular end-diastolic pressure
(LVEDP), EMD 96 785 had a significantly greater dp/
dtmax compared with that seen in control animals at the 30-
and 60-minute post-CPB/CPA time periods. This parallels
the PRSW data. Figure 3 shows no difference between
groups in arterio–coronary sinus lactate difference, which
suggests an equivalent global ischemic insult. There was no
difference in levels of the cardiac enzymes creatine kinase,
lactate dehydrogenase, or troponin I between groups. Myo-
cardial tissue MPO was almost identical between groups
(control: 0.29  0.04 U/100 mg of tissue vs EMD 96 785:
0.31  0.07 U/100 mg of tissue).
Morphometric evaluation demonstrated myocardium with
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25.6%  1.8% volume interstitial space in control animals
compared with 24.7%  2.0% in animals receiving EMD 96
785 (P .37). Normal cardiomyocytes were 60.0% 3.9% in
control animals and 53.0% 4.0% in animals receiving EMD
96 785 (P  .1). Cardiomyocytes with contraction band for-
mation were 14.3%  4.0% in control animals and 22.3% 
4.5% in animals receiving EMD 96 785 (P  .11).
Discussion
Our study shows that Na/H-exchanger inhibition be-
fore and during myocardial ischemia reduces myocardial
edema formation during CPB/CPA. In addition, the rapid
increase of reperfusion-induced myocardial water accumula-
tion in control animals was attenuated by Na/H-exchanger
inhibition. Apparently, post-CPB functional recovery was en-
hanced by edema reduction. Our central hypothesis was that
Na/H-exchanger inhibition reduces myocardial edema
formation associated with CPB/CPA. However, the differ-
entiation between interstitial myocardial edema versus in-
tracellular myocardial edema was not determined. Intersti-
tial myocardial edema is primarily related to altered Starling
forces and a loss of the myocardial edema safety factors
during CPA. These include the cessation of myocardial
lymph flow without organized contraction, reduction of
interstitial pressure with diastolic arrest, and reduction of
plasma oncotic pressure with crystalloid cardioplegia.2 This
is apparent in Figure 1, which shows that MWC increases
abruptly. Thus, we would not expect Na/H-exchanger
inhibition to affect interstitial edema. EMD 96 785 affects
intracellular edema by reducing Na and water influx into
Figure 1. MWC increases in both groups after CPB/CPA. EMD 96 785 pretreatment results in significantly less
myocardial edema compared with that seen in control animals. *P < .05 compared with control animals. BL,
Baseline; CP, cardioplegia; REP, reperfusion.
Cardiopulmonary Support and Physiology Cox et al
962 The Journal of Thoracic and Cardiovascular Surgery ● May 2002
CSP
the cell.11-13 Although morphometric analysis can yield vari-
able information caused by sampling errors or fixation artifact,
our data show no significant difference in the interstitial space
volume between control animals and animals receiving EMD
96 785. This suggests that the increase in MWC occurred in the
intracellular, and not in the interstitial, space. Because these
samples were taken at the end of the experiment, when the
differences in MWC were not as pronounced, the microscopic
techniques may have not differentiated between the differ-
ences in intracellular and interstitial water.
The sequence of events that determines the degree of
cellular edema and Na gain after I-R has not been irrefut-
ably determined. However, a number of studies describe
mechanisms explaining how Na/H-exchanger inhibition
can reduce myocardial edema after I-R.11,21,22 Na/H ex-
change is an osmolar equivalent exchange. During hypoxia-
ischemia, Na/H exchange alone has no effect on osmo-
lality, and Cl/HCO3 exchange that operates in the
absence of intracellular acidosis is inhibited. However, with
reperfusion, cytosolic Na is not rapidly normalized but
remains increased for a prolonged period of time. During
this time, intracellular pH rapidly increases, allowing Cl/
HCO3 exchange to operate and driving external Cl in-
ward. Thus, even though the antiporter catalyzes the strictly
coupled exchange of one osmolyte for another, exchange of
Na for H results in net osmotic gain for 2 reasons. As
Na moves inward and H outward, the intracellular con-
centration and activity of H is simultaneously compen-
sated by dissociation of intracellular buffers. The associated
increase in intracellular pH prompts exchange of intracel-
lular HCO3 with inward flow of Cl. Together, the parallel
stimulation of the cation and anion antiporters promotes the
uptake of NaCl coupled to osmotic water uptake, thereby
favoring intracellular myocardial edema.
The contribution of myocardial edema to the multifacto-
rial post-CPB/CPA myocardial dysfunction is controversial.
It is reasonably well established that myocardial edema
impairs diastolic function, increasing myocardial stiffness.
Ludwig and colleagues23 showed that modest myocardial
edema without preceding I-R depressed systolic function as
Figure 2. PRSW decreases in both groups after CPB/CPA. EMD 96 785 pretreatment results in improved myocardial
contractility after CPB/CPA. *P < .05 compared with control animals; #P < .05 compared with baseline. BL,
Baseline.
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well. In contrast, Miyamoto and coworkers24 later demon-
strated no depression of systolic function with induction of
myocardial edema without preceding I-R. However, we
have shown that myocardial edema without preceding isch-
emia impairs cardiac performance.25 Data from the current
study are similar to those of previous studies demonstrating
that increases of 1% to 2% in MWC after CPB/CPA sig-
nificantly depress PRSW.2-5 The degree and time course of
myocardial edema development-resolution after CPB/CPA
are clinically relevant because this is the critical period
immediately after separation from CPB. Myocardial perfor-
mance during this time determines the need to reinstitute
CPB or circulatory support devices, as well as inotropes.
Our data show an improvement in post-CPB/CPA myo-
cardial contractility after pretreatment with EMD 96 785,
primarily in the first hour after separation from CPB, with a
return to control values at 2 hours after separation from
CPB. The observed preservation of myocardial contractility
in animals receiving EMD 96 785 is associated with a
reduction in MWC compared with that seen in control
animals. However, Na/H-exchanger inhibition during
myocardial I-R could affect contractility directly, irrespec-
tive of changes in myocardial water. The Na/H ex-
changer normalizes intracellular pH during intracellular
acid (lactate) accumulation that can occur with myocardial
ischemia.11,12,26 During reperfusion, lactate is removed, and
there is an alkaline overshoot.9 Intracellular alkalinization
has a potent sensitizing effect of myocardial contractile pro-
teins to Ca2. Thus, impaired diastolic relaxation may occur
not only because of increased intracellular Ca2 but also be-
cause of increased Ca2-troponin interactions. This is one of
the reported mechanisms of postreperfusion-induced myo-
cardial contracture and loss of myocardial compliance.9
Increased Na/H-exchanger activity during ischemia
results in an increased Na influx into the cell. A secondary
effect of this phenomenon is a reversal of the Na/Ca2
exchanger, resulting in an increase in intracellular
Ca2.11,12,26 Increased intracellular Ca2 within the myo-
cyte may alter the Ca2 kinetics of excitation-contraction
coupling or Ca2 cycling between the contractile apparatus
Table 1. Hemodynamic parameters
Baseline 30 min after CPB 60 min after CPB
120 min after
CPB
MAP (mm Hg)
Control 125 2 75 5*† 90 6† 106 7†
EMD 96 785 120 6 98 3 109 3 107 7
dp/dtmax
Control 2159 153 1514 92*† 1824 81* 2147 73
EMD 96 785 2340 267 2261 102 2601 213 2088 143
dp/dtmax
Control 3082 260 1827 208*† 2267 186*† 2477 131
EMD 96 785 3643 170 2949 271† 2956 200 2342 219†
LVEDP (mm Hg)
Control 2 0 2 0 2 0 2 0
EMD 96 785 1 0 2 0 2 0 3 0
LVEDV (mL)
Control 33 6 28 6 28 5 30 6
EMD 96 785 27 4 26 3 27 4 27 5
PAOP (mm Hg)
Control 10 1 10 0 10 0 10 1
EMD 96 785 9 0 9 0 9 0 9 0
CVP (mm Hg)
Control 7 0 7 0 7 0 8 0
EMD 96 785 6 0 6 0 6 0 7 0
CI
Control
(L  min1  m2)
2.9 0.2 1.7 0.3† 1.9 0.2† 1.9 0.3†
EMD 96 785 2.5 0.2 1.9 0.1 1.9 0.2 2.0 0.3
At the same left ventricular end-diastolic volume in each group, dp/dtmax is significantly greater at 30 and 60 minutes after CPB in animals receiving EMD
96 785 compared with that in control animals. This parallels the PRSW data. Mean arterial pressure is decreased to a greater degree in control animals
compared with animals receiving EMD 96 785 at 30 and 60 minutes after CPB. – dp/dtmax is greater in animals receiving EMD 96 785 compared with control
animals at 30 and 60 minutes after CPB. This suggests an improvement in diastolic function in the EMD 96 785 group compared with that in the control
group. MAP, Mean arterial pressure; dp/dt, derivative change in left ventricular pressure over time; LVEDP, left ventricular end-diastolic pressure; PAOP,
pulmonary artery occlusion pressure; CVP, central venous pressure; CI, cardiac index.
*P  .05 compared with control value at same time point.
†P  .05 compared with baseline value within group.
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and the sarcoplasmic reticulum, leading to myocardial con-
tracture with a resultant rise in LVEDP, stone heart, or both.
Numerous studies have demonstrated attenuation in the
expected rise in LVEDP after myocardial I-R by using
Na/H-exchanger inhibition.7-9 Increased intracellular
Ca2 may initiate reperfusion-induced arrhythmias through
a mechanism involving oscillatory release of Ca2 from the
sarcoplasmic reticulum, thus inducing delayed afterpolar-
izations.10,27 Therefore, Na/H-exchanger inhibition may
improve post-CPB/CPA myocardial contractility and func-
tion in 4 ways: (1) limiting intracellular Na gain (and
water) during myocardial ischemia; (2) suppressing postre-
perfusion contractile and diastolic dysfunction caused by
myofilament sensitization by the alkaline overshoot; (3)
limiting intracellular Ca2 overload with secondary hyper-
contracture, progression to infarction,28 or both; and (4)
preventing Ca2 overload–mediated reperfusion arryth-
mias.10,27 We were unable to determine the relative contri-
bution of a reduction of MWC toward improved post-CPB/
CPA myocardial contractility.
Our secondary hypothesis was that Na/H-exchanger
inhibition attenuated polymorphonuclear neutrophil (PMN)-
mediated myocardial reperfusion injury. Faes and col-
leagues16 demonstrated that Na/H-exchanger inhibition
improved in vitro contractile function and decreased myo-
cardial injury when hearts were perfused with stimulated
PMNs. Our study did not directly evaluate PMN-mediated
myocardial injury. However, we infer that Na/H-ex-
changer inhibition probably does not alter PMN-mediated
myocardial I-R injury because there is no difference in
myocardial leukosequestration between groups. If Na/H-
exchanger inhibition altered local or systemic PMN prim-
Figure 3. Arterio– coronary sinus lactate difference is used as a marker of degree of myocardial ischemia during
CPB/CPA. There is no difference between groups, indicating equivalent I-R injury. #P < .05 compared with
baseline. BL, Baseline; REP, reperfusion.
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ing-activation, myocardial leukosequestration should de-
crease and be reflected in decreased myocardial MPO.
As with any technique that models the clinical situation,
there are inherent limitations to this study. First and fore-
most is that healthy animals, and not human subjects, with
ischemic hearts were used. Moreover, dogs may be more
prone to development of myocardial edema than human
subjects. Finally, many myocardial protection techniques in
use today may alter these results, including temperature,
methods of reperfusion, and the use of blood and various
other drugs as perfusate additives.
In summary, Na/H-exchanger inhibition delivered be-
fore global myocardial I-R in a clinically relevant model of
CPB/CPA improved post-CPB/CPA myocardial contractil-
ity and edema formation. This effect does not appear to be
related to PMN-mediated myocardial injury.
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